Abdullah Jahangir, MD

Articles by Abdullah Jahangir, MD

Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

ByMuhammad Rafay Khan Niazi, MD,Abdullah Jahangir, MD,Syeda Sahra, MD,Saud Bin Abdul Sattar, MD,Divya Asti, MD,Alexander Bershadskiy, MD

November 18th 2021

The aim of this meta-analysis is to analyze the efficacy of these drugs in the treatment of mCRPC in terms of progression-free survival (PFS) and overall survival (OS), using the results of completed trials.

Latest Updated Articles

Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials
Published: November 18th 2021 | Updated:

Abdullah Jahangir, MD

Articles by Abdullah Jahangir, MD

Efficacy of PARP Inhibitors as Maintenance Therapy for Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis of Randomized Controlled Trials

Latest Updated Articles

Trending on CancerNetwork

How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?

Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma

Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma

64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC

FDA Grants Fast Track Designation to NG-350A For pMMR Rectal Cancer